Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

1700022C21Rik Inhibitors

Chemical inhibitors of 1700022C21Rik can exert their effects through various biochemical pathways by directly targeting enzymes and kinases that are implicated in its regulation and function. Staurosporine is a potent protein kinase inhibitor, which can disrupt the phosphorylation processes essential for the activity of 1700022C21Rik. Similarly, Bisindolylmaleimide I specifically inhibits protein kinase C, a kinase that could phosphorylate 1700022C21Rik, thereby inhibiting its activity. SP600125 serves as an inhibitor of JNK, which is involved in the signaling pathways that regulate the functionality of 1700022C21Rik, leading to its inhibition. SB203580, by inhibiting p38 MAP kinase, potentially alters the phosphorylation status of 1700022C21Rik, which is crucial for its activity. PD98059, a selective inhibitor of MEK, can prevent the activation of ERK, which may be necessary for the function of 1700022C21Rik, resulting in its inhibition.

Continuing with the mechanisms of action, LY294002, a PI3K inhibitor, disrupts the PI3K/Akt pathway, which can be critical for 1700022C21Rik's activity. Rapamycin targets mTOR, a kinase that can regulate the function of 1700022C21Rik through several downstream signaling pathways. U0126 also inhibits MEK, consequently preventing the activation of ERK and potentially impeding the functional activity of 1700022C21Rik. Wortmannin, another PI3K inhibitor, can prevent the activation of pathways that 1700022C21Rik may be involved in. PP2, through its inhibitory action on Src family kinases, can disrupt signaling pathways that involve the phosphorylation of 1700022C21Rik. AG490 inhibits JAK2 kinase, interfering with the JAK-STAT signaling pathway, which could regulate 1700022C21Rik. Lastly, PD173074, an FGFR inhibitor, can inhibit the fibroblast growth factor receptor pathways that 1700022C21Rik may be part of, leading to its functional inhibition. Each of these inhibitors, through their specific action on kinases and receptors, can contribute to the inhibition of 1700022C21Rik by disrupting the necessary signaling cascades and phosphorylation events that are essential for its proper functioning.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Inhibits protein kinases, which could be involved in phosphorylating 1700022C21Rik, leading to its functional inhibition.

Bisindolylmaleimide I (GF 109203X)

133052-90-1sc-24003A
sc-24003
1 mg
5 mg
$105.00
$242.00
36
(1)

Specific inhibitor of protein kinase C, which may phosphorylate 1700022C21Rik, thereby inhibiting its function.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits JNK, which might be necessary for the activation or function of 1700022C21Rik, thereby inhibiting the protein's function.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

Inhibits p38 MAP kinase, potentially impacting the phosphorylation state and function of 1700022C21Rik.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

Selectively inhibits MEK, which is upstream of ERK, possibly involved in the functional regulation of 1700022C21Rik.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor which would disrupt downstream signaling required for the function of 1700022C21Rik.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Inhibits mTOR, a kinase that may regulate 1700022C21Rik function through downstream signaling pathways.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

MEK inhibitor that prevents the activation of ERK, potentially necessary for the function of 1700022C21Rik.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Inhibits PI3K and could prevent activation of downstream signaling pathways involving 1700022C21Rik.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$94.00
$227.00
30
(1)

Src family kinase inhibitor that could disrupt signaling pathways involving the phosphorylation of 1700022C21Rik.